>> According to a television show, 2 members of the FDA are under investigation for allowing Viagra fast track approval (or for actually approving the drug). These 2 individuals were on Pfizers payroll.<<
Nonsense. It would be nice if you wouldn't spread undigested misinformation - just as it would be nice if you would share the "source" of the supposed "public information" that "at least 5" VVUS insiders are buying up a storm: Message 7726906 Message 7732391 and Message 7739641 . (Is there anyone who doesn't infer from your refusal to identify what you claim is a public source for this fact that you are making up that supposed fact as well?)
It wasn't two FDA commissioners "on Pfizer's payroll", which would be a very big deal if true, and very much in the headlines. The story is much more minor, and irrelevant to VVUS's investment value: two of the authors of a survey of sexual satisfaction and dysfunction, published in the JAMA this week, were not identified in JAMA as having been paid consultants to Pfizer (although the failure to identify them as Pfizer consultants was apparently JAMA's fault, not the authors):
". . . . two of the authors had served as paid consultants to Pfizer, the manufacturer of Viagra, which could see a doubling of its market for the drug if the studies in women were to pan out. The authors' financial connection was not mentioned, due to "an oversight" at the Journal of the American Medical Association, according to Dr. Richard Glass, an editor there.
"Pfizer did not pay for the sex survey, but the authors' relationship with the company raised questions nonetheless, because drug companies have an obvious interest in research that suggests expanded uses for their products." (http://www.nytimes.com/library/review/021499sex-medicine-review.html )
|
